Mineralys CMO exercises and sells 2,170 shares
Mineralys Therapeutics Chief Medical Officer David Malcom Rodman exercised 2,170 stock options for Common Stock at an exercise price of $16.00 per share on August 10, 2026, then sold 2,170 Common shares at $27.09 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Mineralys Therapeutics Chief Medical Officer David Malcom Rodman exercised 2,170 stock options for Common Stock at an exercise price of $16.00 per share on August 10, 2026, then sold 2,170 Common shares at $27.09 per share. The option exercise and related sale were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025. Following the transaction, he held 13,024 stock options directly.
Insider Trade Summary 10b5-1
Exercise and Sale: 2,170 shares ($24K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Rodman David Malcom
Role
Chief Medical Officer
Sold
2,170 shs ($59K)
Approx. gross sale proceeds
$59K
Approx. exercise cost
$35K
Approx. pre-tax spread
$24K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F2 | 2,170 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 2,170 | $16.00 | $35K |
| Sale | Common Stock F1 | 2,170 | $27.09 | $59K |
Holdings After Transaction:
Stock Option — 13,024 contracts (Direct);
Common Stock — 51,384 shares (Direct)
Footnotes (2)
- F1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.
- F2. The stock option vests as to 25% of the total number of shares of Common Stock subject to the option on the first anniversary of the grant date, and as to 1/48th of the total number of shares of Common Stock subject to the option on each monthly anniversary thereafter.
Key Figures
Options exercised: 2,170 shares
Exercise price: $16.00 per share
Shares sold: 2,170 shares
+4 more
7 metrics
Options exercised
2,170 shares
Stock Option for Common Stock exercised on August 10, 2026
Exercise price
$16.00 per share
Exercise or conversion price of Stock Option
Shares sold
2,170 shares
Common Stock sale on August 10, 2026
Sale price
$27.09 per share
Price for Common Stock sale transaction
Options held after transaction
13,024 options
Total Stock Options following derivative transaction
Option expiration date
February 9, 2033
Expiration date of the Stock Option exercised
10b5-1 plan adoption date
October 6, 2025
Date the Rule 10b5-1 trading plan was adopted
Key Terms
Rule 10b5-1 trading plan, Stock Option, exercise or conversion of derivative security, Common Stock
4 terms
Rule 10b5-1 trading plan financial
"These transactions were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option financial
"The stock option vests as to 25% of the total number of shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
Common Stock financial
"shares of Common Stock subject to the option on each monthly anniversary"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MLYS Chief Medical Officer David Malcom Rodman report in this Form 4?
He exercised 2,170 stock options at $16.00 per share and sold 2,170 Common shares at $27.09 per share on August 10, 2026, under a Rule 10b5-1 plan.
How many Mineralys Therapeutics (MLYS) options does the CMO hold after this transaction?
After the reported option exercise, he held 13,024 stock options directly. This figure reflects the total stock options reported as outstanding following the derivative transaction in the Form 4.
What prices were involved in the MLYS CMO’s August 10, 2026 transactions?
The stock options were exercised at an exercise price of $16.00 per share, and the resulting 2,170 Common shares were sold at a sale price of $27.09 per share on the same date.
Were the MLYS CMO’s trades made under a Rule 10b5-1 trading plan?
Yes. The Form 4 states the transactions were effected pursuant to a Rule 10b5-1 trading plan that was adopted on October 6, 2025, indicating they followed a pre-arranged schedule.
What type of derivative security did the MLYS CMO exercise?
He exercised a Stock Option for 2,170 shares of Common Stock, described as an exercise or conversion of derivative security with an expiration date of February 9, 2033, and a $16.00 exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
